A Phase I Study of AZD2281 in Combination With Irinotecan in Patients With Locally Advanced or Metastatic Incurable Colorectal Cancer.

Trial Profile

A Phase I Study of AZD2281 in Combination With Irinotecan in Patients With Locally Advanced or Metastatic Incurable Colorectal Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Apr 2016

At a glance

  • Drugs Irinotecan (Primary) ; Olaparib (Primary)
  • Indications Colorectal cancer
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 13 Apr 2016 Results published in the Investigational New Drugs
    • 21 Sep 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 20 Jun 2013 Planned end date changed from 1 Nov 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top